Join to view full profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Dr. Moore is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1996 - 1997
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1993 - 1996
Case Western Reserve University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 2003 - Present
OH State Medical License 1999 - 2028
IL State Medical License 2002 - 2020
NY State Medical License 2003 - 2020
MI State Medical License 2002 - 2018
PA State Medical License 1996 - 2006
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2014, 2016-2017
Clinical Trials
- S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
- Fatigue Caused by Chemotherapy in Women Who Have Undergone Surgery for Breast Cancer and in Healthy Volunteers
Publications & Presentations
PubMed
- Disparities in Breast Cancer Diagnosis, Treatment, and Outcomes Among South Asian American Women.Jasmin Hundal, Ishan Gupta, Ashiya Loomba, Yanwen Chen, Halle Moore
Cancers. 2026-09-04 - 5 citationsUpdated results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) trial.O Pagani, S M Niman, M Ruggeri, F A Peccatori, H A Azim Jr
Annals of Oncology. 2026-09-01 - Surgical Management of Early-Onset Breast Cancer Among Young BRCA1 and BRCA2 Carriers.Stephanie M Wong, Eva Blondeaux, Virginia Delucchi, Florence Coussy, Rinat Bernstein Molho
JAMA Network Open. 2026-08-03
Authored Content
- Pondering the RxPONDER StudyDecember 2020
Press Mentions
VIDEO: OlympiA Trial Shows Olaparib’s Benefits for Patients with BRCA Mutations ‘Persist’December 24th, 2024- VIDEO: Risk-Reducing Surgeries Result in ‘Fewer Breast Cancer Events’ for BRCA CarriersDecember 23rd, 2024
- Merck-AstraZeneca Breast Cancer Drug Reduces Risk of Death by 28% in Patients Diagnosed Early, Clinical Trial ShowsDecember 21st, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
